J.W. Coons Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
J.W. Coons Advisors's BMY Position: Q2 2025 in Review
J.W. Coons Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2025 at 19,520 shares worth $904K. The position accounts for 0.2% of the portfolio, ranked #108.
J.W. Coons Advisors first reported a position in BMY in Q1 2020 and has held it in 22 quarters since. The position peaked at $1.67M in Q4 2022. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- J.W. Coons Advisors held 19,520 shares of Bristol-Myers Squibb worth $904K as of Q2 2025.
- J.W. Coons Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2025.
- Bristol-Myers Squibb made up 0.2% of J.W. Coons Advisors's portfolio in Q2 2025, its #108 holding.
- J.W. Coons Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 22 quarters since.
- J.W. Coons Advisors's Bristol-Myers Squibb position peaked at $1.67M in Q4 2022.
- 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.